These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 8296652)
1. ANCA and anti-GBM antibodies in RPGN. Short AK; Esnault VL; Lockwood CM Adv Exp Med Biol; 1993; 336():441-4. PubMed ID: 8296652 [TBL] [Abstract][Full Text] [Related]
2. [Rapid-detection GBM-ANCA ELISA. An emergency tool for the early diagnosis of type I and II rapidly progressive glomerulonephritis]. Arranz O; Ara J; Rodríguez R; Poveda R; Serra A; Solé-Amigó J; Fort J; Mirapeix E; Darnell A Nefrologia; 2001; 21(4):349-54. PubMed ID: 11816510 [TBL] [Abstract][Full Text] [Related]
3. Dual myeloperoxidase-antineutrophil cytoplasmic antibody- and antiglomerular basement membrane antibody-positive cases associated with prior pulmonary fibrosis: a report of four cases. Nakabayashi K; Fujioka Y; Nagasawa T; Kimura T; Kojima K; Arimura Y; Yamada A Clin Exp Nephrol; 2011 Apr; 15(2):226-34. PubMed ID: 21246240 [TBL] [Abstract][Full Text] [Related]
4. Anti-neutrophil cytoplasm antibodies and anti-glomerular basement membrane antibodies: two coexisting distinct autoreactivities detectable in patients with rapidly progressive glomerulonephritis. Short AK; Esnault VL; Lockwood CM Am J Kidney Dis; 1995 Sep; 26(3):439-45. PubMed ID: 7544065 [TBL] [Abstract][Full Text] [Related]
5. Antineutrophil cytoplasmic autoantibodies with myeloperoxidase specificity in a patient with anti-glomerular basement membrane disease. Wanten GJ; Koolen MI; Harthoorn-Lasthuizen EJ; van Liebergen FJ; Haverman JF; Assmann KJ Neth J Med; 1995 Jul; 47(1):25-9. PubMed ID: 7651563 [TBL] [Abstract][Full Text] [Related]
6. [A case of progressive systemic sclerosis with crescentic glomerulonephritis associated with myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) and anti-glomerular basement membrane antibody (anti-GBM Ab)]. Kobayashi M; Saito M; Minoshima S; Arimura Y; Nagasawa T Nihon Jinzo Gakkai Shi; 1995 Mar; 37(3):207-11. PubMed ID: 7731110 [TBL] [Abstract][Full Text] [Related]
7. [Case of scleroderma with rapid progressive glomerulonephritis associated with both MPO-ANCA and anti-GBM antibodies]. Namba T; Hatanaka M; Takahashi A; Takeji M; Takahara K; Uzu T; Yamauchi A Nihon Jinzo Gakkai Shi; 2008; 50(1):64-8. PubMed ID: 18318246 [TBL] [Abstract][Full Text] [Related]
8. Anti-nuclear, anti-neutrophil cytoplasmic and anti-glomerular basement membrane antibodies in HIV-infected individuals. Savige JA; Chang L; Horn S; Crowe SM Autoimmunity; 1994; 18(3):205-11. PubMed ID: 7858105 [TBL] [Abstract][Full Text] [Related]
9. MPO-ANCA-positive anti-glomerular basement membrane antibody disease successfully treated by plasma exchange and immunosuppressive therapy. Murakami T; Nagai K; Matsuura M; Kondo N; Kishi S; Araoka T; Kishi F; Sakiyama T; Mima A; Bando Y; Abe H; Doi T Ren Fail; 2011; 33(6):626-31. PubMed ID: 21599422 [TBL] [Abstract][Full Text] [Related]
10. Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis. Rutgers A; Slot M; van Paassen P; van Breda Vriesman P; Heeringa P; Tervaert JW Am J Kidney Dis; 2005 Aug; 46(2):253-62. PubMed ID: 16112043 [TBL] [Abstract][Full Text] [Related]
11. Anti-neutrophil cytoplasmic autoantibodies (ANCA): antigenic specificities and clinical associations. Bosch X; Font J; Mirapeix E; Revert L; Urbano-Márquez A; Ingelmo M Adv Exp Med Biol; 1993; 336():281-6. PubMed ID: 8296618 [TBL] [Abstract][Full Text] [Related]
12. Classic and perinuclear anti-neutrophil cytoplasm antibodies and antimyeloperoxidase antibodies in rapidly progressive glomerulonephritis. Rollino C; Roccatello D; Coppo R; Menegatti E; Basolo B; Giraudo G; Martina G; Piccoli G Am J Nephrol; 1991; 11(4):318-24. PubMed ID: 1665954 [TBL] [Abstract][Full Text] [Related]
13. Myeloperoxidase anti-neutrophil cytoplasmic autoantibodies (MPO-ANCA)-related rapidly progressive glomerulonephritis (RPGN) and pulmonary fibrosis (PF) with dissociated evolution. Souid M; Terki NH; Nochy D; Hillion D Clin Nephrol; 2001 Apr; 55(4):337-8. PubMed ID: 11334325 [No Abstract] [Full Text] [Related]
17. Some patients with anti-myeloperoxidase autoantibodies have a C-ANCA pattern. Segelmark M; Baslund B; Wieslander J Clin Exp Immunol; 1994 Jun; 96(3):458-65. PubMed ID: 7516271 [TBL] [Abstract][Full Text] [Related]
18. Anti-neutrophil cytoplasmic antibodies in patients with systemic lupus erythematosus. Waldendorf M; Schneider M Adv Exp Med Biol; 1993; 336():381-4. PubMed ID: 8296640 [TBL] [Abstract][Full Text] [Related]
19. [An experience of treatment of double positive myeloperoxidase-antineutrophil cytoplasmic antibodies (MPO-ANCA) and anti-glomerular basement membrane antibodies in Goodpasture's syndrome onset of crescentic glomerulonephritis]. Takeda T; Takeda T; Naiki Y; Yonekawa S; Sakaguchi M; Iwamoto I; Tanaka H; Hasegawa H; Imada A; Kanamaru A; Hiruma S; Maekura S; Hashimoto S; Yamazumi T Nihon Jinzo Gakkai Shi; 1998 Nov; 40(8):591-6. PubMed ID: 9893458 [TBL] [Abstract][Full Text] [Related]
20. Role of antineutrophil cytoplasmic antibodies and glomerular basement membrane antibodies in the diagnosis and monitoring of systemic vasculitides. Sinclair D; Stevens JM Ann Clin Biochem; 2007 Sep; 44(Pt 5):432-42. PubMed ID: 17761028 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]